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Abstract
The costimulatory protein B7-H3 has been shown to play a contributory role in the develop-
ment and progression of experimental pneumococcal meningitis by augmentation of the
innate immunity-associated inflammatory response via a TLR2-dependent manner. This
study aimed to clarify the component(s) of TLR2-mediated signal transduction pathways
responsible for B7-H3-augmented inflammatory response and subsequent brain damage
during experimental pneumococcal meningitis. Administration of B7-H3 did not augment
expression of TLR2 and other TLR2 upstream components, but led to an enhanced formation
of MyD88-IRAK immunocomplex in the brain of S. pneumoniae-infected mice. Furthermore,
B7-H3 substantially augmented S. pneumoniae-induced activation of TLR2 downstream NF-
κB p65 and MAPK p38 pathways in the brain of S. pneumoniae-infected mice. Notably, block-
age of NF-κB p65 and/or MAPK p38 with their specific inhibitors strongly attenuated B7-H3-
amplified inflammatory response with significantly reduced proinflammatory cytokine and
chemokine production, and markedly ameliorated B7-H3-exacerbated disruption of blood-
brain barrier and severity of disease status in S. pneumoniae-infected mice. These results
indicate that targeting NF-κB p65 and/or MAPK p38 may represent a promising therapeutic
option for amelioration of overwhelming inflammatory response-associated brain injury fre-
quently observed during pneumococcal meningitis.
Introduction
Bacterial meningitis is among the top 10 causes of infection-related deaths worldwide and
many survivors suffer from permanent neurological sequelae [1]. Bacterial meningitis caused
by Streptococcus pneumoniae (S. pneumoniae) is the principal and most frequent etiological
agent for bacterial meningitis in humans and accounts for more than half of all cases [2,3].
Pneumococcal meningitis remains a life-threatening infectious disease in both adults and
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children, and causes death in approximately 25% of cases and neurological sequelae in nearly
half of survivors despite targeted antibiotic therapy, adjunctive treatment with steroids, and
supportive intensive care [4–7]. It has been well established that the poor outcome of pneumo-
coccal meningitis is often associated with the development of intracranial complications such
as brain edema and cerebrovascular damage [8,9]. Mounting evidence has shown that the
development and progression of pneumococcal meningitis and its intracranial complications
are not only due to an uncontrolled bacterial growth in the central nervous system (CNS), but
also dependent largely on the host innate immunity-initiated inflammatory response through
the recognition of pathogen-associated molecular patterns (PAMPs) on the invaded microbial
pathogens by the pattern recognition receptors (PRRs) such as toll-like receptor 2 (TLR2) and
its adaptor protein myeloid differentiation factor 88 (MyD88) [10–12]. S. pneumoniae infec-
tion of the meninge often generates an overwhelming inflammatory reaction via both TLR2-
and MyD88-dependent production of proinflammatory cytokines and chemokines [11–13].
Although the inflammatory response triggered by S. pneumoniae infection normally helps to
eradicate the invaded microbial pathogens from the CNS, a persistent and/or amplified activa-
tion of this reaction with the excessive production of proinflammatory cytokines in the CNS
may cause severe damage to the brain, thus contributing to a frequently unfavorable outcome
during the development of pneumococcal meningitis [8,10,14].
B7-H3 is a newly discovered member of the B7 costimulatory protein superfamily and has
been identified in both humans and mice by sharing *88% amino acid sequence identity
[15,16]. Accumulated evidence supports the notion that B7-H3 functions as both a T cell costi-
mulator and coinhibitor, thus possessing a contrasting role in regulation of Ag-specific T cell-
mediated immune responses [16–19]. More recently, B7-H3 has been shown to participate in
the innate immunity-associated inflammatory response. B7-H3 is inducible in human mono-
cytes/macrophages and dendritic cells upon inflammatory cytokine stimulation [16,20]. Our
recent work demonstrated an inflammation-based action of B7-H3 by augmenting both the
TLR2 agonist bacterial lipoprotein (BLP)- and the TLR4 agonist lipopolysaccharide (LPS)-
stimulated nuclear factor-kappaB (NF-κB) activation and proinflammatory cytokine produc-
tion in monocytes/macrophages [21]. Patients diagnosed with bacterial meningitis displayed
significantly elevated soluble B7-H3 (sB7-H3) in the circulation and cerebrospinal fluid (CSF),
and levels of sB7-H3 in these patients correlated closely with the intensity of their infectious
inflammatory process in the CNS [22]. In a murine model of pneumococcal meningitis, we
found that B7-H3 strongly enhanced S. pneumoniae-stimulated proinflammatory cytokine and
chemokine expression in the brain via a TLR2-dependent mechanism, and this B7-H3-ampli-
fied inflammatory response further exacerbated S. pneumoniae-induced disruption of blood-
brain barrier (BBB) integrity and brain damage [13,23], indicating that B7-H3 participates in
the development of pneumococcal meningitis via augmentation of the innate immunity-asso-
ciated inflammatory response.
In the present study, we investigated the impact of B7-H3 on activation of TLR2 signaling in
a murine model of pneumococcal meningitis, in an attempt to clarify the component(s) of
TLR2-mediated signal transduction pathways responsible for B7-H3-induced amplification of
inflammatory responses and subsequent brain damage. We reported here that administration
of B7-H3 resulted in an enhanced formation of MyD88-IL-1 receptor-associated kinase (IRAK)
immunocomplex and augmented activation of TLR2 downstream NF-κB p65 and mitogen-
activated protein kinase (MAPK) p38 in S. pneumoniae-infected mice. Remarkably, blockage of
either NF-κB p65 or MAPK p38 attenuated B7-H3-amplified inflammatory response with sig-
nificantly reduced proinflammatory cytokine and chemokine production, and ameliorated
B7-H3-exacerbated BBB disruption and brain damage in S. pneumoniae-infected mice.
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Materials and Methods
Reagents, antibodies, and bacteria
Recombinant mouse B7-H3 was purchased from R&D Systems (Minneapolis, MN, USA). Anti-
bodies (Abs) that recognize TLR2, MyD88, and IRAK-1 were purchased from Santa Cruz Bio-
technology (Santa Cruz, CA, USA) and Abcam (Cambridge, MA, USA), respectively. Abs that
recognize NF-κB p65, phospho-p65 at Ser536, MAPK p38, and phospho-p38 at Thr180/Tyr182
were purchased from Santa Cruz Biotechnology and Cell Signaling Technology (Beverly, MA,
USA), respectively. The MAPK p38 inhibitor SB203580 and NF-κB p65 inhibitor PDTC were
obtained from Cell Signaling Technology and Merk Millipore (Billerica, MA, USA), respec-
tively. All other chemicals, unless indicated, were from Sigma-Aldrich (St. Louis, MO, USA).
Gram-positive S. pneumoniae type 3 was obtained from American Type Culture Collection
(ATCC, Manassas, VA, USA). Bacteria were cultured at 37˚C in trypticase soy broth (Merck,
Darmstadt, Germany), harvested at the mid-logarithmic growth phase, washed twice, and
resuspended in PBS. The concentration of resuspended bacteria was determined and adjusted
spectrophotometrically at 550 nm.
Mice and pneumococcal meningitis
Pyrogen-free, 8- to 10-week old male Balb/c mice were purchased from Slac (Shanghai, China).
Mice were housed in barrier cages under controlled environmental conditions (12/12 hrs of
light/dark cycle, 55% ± 5% humidity, 23˚C) in the Pediatric Research Institute of Soochow Uni-
versity and had free access to standard laboratory chow and water. Animals were fasted 12 hrs
before experiments and allowed water ad libitum. All animal studies were ethically approved by
the institutional animal care and use committee at Soochow University and complied with the
animal welfare act. The methods applied in this study were carried out in accordance with the
approved guidelines.
Age- and weight-matched male Balb/c mice were anesthetized by intramuscular injection
of 150 μl ketamine/xylazine admixture (150 μl ketamine plus 150 μl xylazine made up to 1 ml
with 0.9% saline). Pneumococcal meningitis was induced by intracerebral ventricular injection
of 15 μl sterile PBS containing 0.75×107 CFU/ml S. pneumoniae (SP) into the lateral ventricle
as described previously [13,23].
Experimental groups and assessment of the clinical disease status
Eight- to ten-week old male Balb/c mice (n = 192 in total) were randomized into one of the fol-
lowing four experimental groups (n = 30 per group) and each mouse received an intracerebral
ventricular injection of 15 μl in total: 1) mice in the control group injected with 15 μl PBS; 2)
mice in the B7-H3 group injected with 15 μl PBS containing 2.5 μg B7-H3; 3) mice in the SP
group injected with 15 μl PBS containing 0.75×107 CFU/ml S. pneumoniae; 4) mice in the SP
plus B7-H3 group injected with 7.5 μl PBS containing 1.5×107 CFU/ml S. pneumoniae and
7.5 μl PBS containing 2.5 μg B7-H3. For blocking NF-κB p65 and/or MAPK p38, mice were
received an intracerebral ventricular injection of 7.5 μl PBS containing equivalent dimethyl
sulfoxide (DMSO), the MAPK p38 inhibitor SB203580 (40 μg/mouse), the NF-κB p65 inhibi-
tor PDTC (100 μg/mouse), or SB203580 plus PDTC (40+100 μg/mouse) 1 hr before mice
treated with PBS, S. pneumoniae, or S. pneumoniae plus B7H3 (n = 24 per group) as described
above. The in vivo study was carried out in two separate experiments.
Mice were weighed, allowed to wake up, and evaluated clinically at 6, 18, and 30 hrs after SP
infection. The clinical disease status was examined by spontaneous motor activity and body
weight loss. The following scores were used to assess spontaneous motor activity of mice as
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described previously [24,25]: 1, normal motor activity and turned upright in <5 s when put
on their back; 2, reduced spontaneous motor activity, but still turned up in <5 s; 3, turned
up in >5 s; 4, did not turn up; 5, did not move at all. At the indicated time points after SP
infection, mice were sacrificed by CO2 inhalation. The brain of each animal was removed,
half of the brain was frozen immediately in liquid nitrogen and stored at -80˚C for quantita-
tive real-time PCR and ELISA, and the other part of the brain was used for immunoblotting
and immunoprecipitation.
Quantitative real-time PCR
TLR2, MyD88, IRAK-1, toll-interleukin 1 receptor domain containing adaptor protein (TIRAP),
TNF receptor-associated factor 6 (TRAF6), TNF-α, IL-1β, IL-6, and MCP-1 mRNA expression
was assessed by quantitative real-time PCR. Total RNA was extracted from frozen brain sections
using a GeneEluteTM mammalian total RNA purification kit (Sigma-Aldrich) and reverse-tran-
scribed into cDNA using the SuperScript first-strand synthesis system (Invitrogen Life Technolo-
gies, Paisley, Scotland, UK). Amplification of cDNA was conducted using a LightCycler system
(Roche Molecular Biochemicals, Indianapolis, IN, USA) according to the manufacturer’s instruc-
tions. The target gene mRNA expression was normalized with the housekeeping gene β-actin.
Gene-specific primers used in this study were listed in Table 1.
ELISA
Brain samples collected at the indicated time points after SP infection were homogenized and
centrifuged. The concentrations of proinflammatory cytokines TNF-α, IL-1β, IL-6 and chemo-
kine MCP-1 in brain homogenates were assessed by ELISA (eBioscience, Hatfield, UK) accord-
ing to the manufacturer’s instructions.
Two endogenous serum abundant proteins albumin and IgG are normally excluded from
the brain by the intact BBB. To assess the BBB integrity, albumin and IgG levels in mouse
brain homogenates collected at 30 hrs after SP infection were assessed by ELISA (RD Biotech,
Besancon, France) (Abnova, Walnut, CA, USA), respectively, according to the manufacturer’s
instructions.
Immunoblotting and immunoprecipitation
At the indicated time points after SP infection, brain samples were collected, homogenized, and
lysed on ice in lysis buffer (Cell Signaling Technology), supplemented with 1 mM phenylmethyl-
sulfonyl fluoride (PMSF) and protease inhibitor cocktail (Roche Molecular Biochemicals). The
Table 1. Gene-specific PCR primers.
Product length (bp) Sense Antisense
Mouse TLR2 231 GCAAACGCTGTTCTGCTCAG AGGCGTCTCCCTCTATTGTATT
Mouse MyD88 175 TCATGTTCTCCATACCCTTGGT AAACTGCGAGTGGGGTCAG
Mouse IRAK-1 195 CCACCCTGGGTTATGTGCC GAGGATGTGAACGAGGTCAGC
Mouse TIRAP 100 CCTCCTCCACTCCGTCCAA CTTTCCTGGGAGATCGGCAT
Mouse TRAF6 125 AAAGCGAGAGATTCTTTCCCTG ACTGGGGACAATTCACTAGAGC
Mouse TNF-α 122 CTGAACTTCGGGGTGATCGG GGCTTGTCACTCGAATTTTGAGA
Mouse IL-1β 116 GAAATGCCACCTTTTGACAGTG TGGATGCTCTCATCAGGACAG
Mouse IL-6 131 CTGCAAGAGACTTCCATCCAG AGTGGTATAGACAGGTCTGTTGG
Mouse MCP-1 121 TTAAAAACCTGGATCGGAACCAA GCATTAGCTTCAGATTTACGGGT
β-actin 211 GTGACGTTGACATCCGTAAAGACC ATCTGCTGGAAGGTGGACAGTGAG
doi:10.1371/journal.pone.0171146.t001
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resultant lysates were centrifuged and supernatants containing the cytoplasmic proteins were
collected. Protein concentrations were determined using a micro BCA protein assay (Pierce,
Rockford, IL, USA). Equal amounts of protein extracts were separated on SDS-polyacrylamide
gels and trans-blotted onto polyvinylidene difluoride (PVDF) membranes (Schleicher & Schuell,
Dassel, Germany). The membrane was blocked for 1 hr at room temperature with PBS contain-
ing 0.05% Tween-20 and 5% nonfat milk, and probed overnight at 4˚C with primary Abs. Blots
were then incubated with appropriate horseradish peroxidase-conjugated secondary Abs (Cell
Signaling Technology) at room temperature for 1 hr, developed with SuperSignal chemilumines-
cent substrate (Pierce), and captured with LAS-3000 imaging system (Fujifilm, Tokyo, Japan).
For immunoprecipitation, equal amounts of extracted protein were incubated with anti-MyD88
Ab overnight at 4˚C on a rotator. Thereafter, 50 μl of 50% slurry of pre-washed protein A/G-aga-
rose beads (Pierce) was added to each sample and incubated at 4˚C for 2 hrs. The samples were
spun briefly and washed three times in the lysis buffer. Loading buffer was added to each sample
and boiled for 10 min. The samples were then separated by SDS-polyacrylamide gels, trans-blot-
ted onto PVDF membranes, and probed with anti-IRAK-1 Ab.
Statistical analysis
All data are presented as the mean ± SD. Statistical analysis was performed with GraphPad
software version 5.01 (Prism, La Jolla, CA, USA). Comparisons between groups were carried
out using one-way ANOVA, followed by Bonferroni correction when necessary, and Mann-
Whitney U test, where appropriate. Differences in spontaneous motor activity and body weight
loss between groups were analyzed using Kruskal-Wallis test. A p value <0.05 was judged sta-
tistically significant.
Results
B7-H3 fails to augment TLR2 and other upstream component
expression, but enhances MyD88-IRAK immunocomplex formation in
the brain of S. pneumoniae-infected mice
To ascertain the component(s) of TLR2-mediated signal transduction pathways responsible for
B7-H3-amplified inflammatory response during pneumococcal meningitis, we first examined
the impact of B7-H3 on expression of TLR2, MyD88, IRAK1, TIRAP, and TRAF6 in brain tis-
sues of S. pneumoniae-infected mice. Significantly increased mRNA expression of TLR2 in
brain homogenates was observed after mice infected with S. pneumoniae compared with mice
treated with PBS (Fig 1A); however, infection of mice with S. pneumoniae did not enhance pro-
tein expression of TLR2 (Fig 1B and 1C). Moreover, administration of B7-H3 was unable to fur-
ther augment S. pneumoniae-stimulated TLR2 expression, as shown in mice challenged with a
combination of S. pneumoniae and B7-H3 in comparison with mice challenged with S. pneumo-
niae alone (Fig 1).
The recruitment of upstream components of TLR2 signaling including MyD88, and IRAK1,
in particular their immunocomplex formation, after engagement of TLR2 with its bacterial
ligands plays a crucial role in TLR2-mediated intracellular signal transduction pathways and
subsequent initiation of inflammatory responses [26–30]. We next assessed the expression of
these upstream components in brain tissues of mice challenged with S. pneumoniae alone or S.
pneumoniae and B7-H3 in combination. As shown in Fig 2, neither S. pneumoniae nor S. pneu-
moniae in combination with B7-H3 affected the mRNA expression of MyD88, IRAK1, TIRAP,
and TRAF6 at all time points measured. However, infection with S. pneumoniae or S. pneumo-
niae in combination with B7-H3 resulted in substantially reduced protein expression of IRAK1
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Fig 1. B7-H3 does not augment TLR2 expression in brain tissues of S. pneumoniae-infected mice.
Mice were challenged with PBS as the control, recombinant mouse B7-H3, live S. pneumoniae (SP), or live S.
pneumoniae plus B7-H3 (SP+B7-H3) via intracerebral ventricular injection as described in the Methods. Brain
samples were collected at the indicated time points after challenges. TLR2 mRNA expression was assessed
by quantitative real-time PCR (A) and data are expressed as mean ±SD of five to six mice per time point and
represent two separate experiments. **p<0.01 compared with mice treated with PBS. TLR2 protein expression
(B) was detected by Western blot analysis and data shown represent one experiment from a total of four separate
experiments. Density ratios of TLR2/GAPDH (n = 4) (C) were quantified by densitometry analysis.
doi:10.1371/journal.pone.0171146.g001
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(Fig 3A and 3C). Furthermore, S. pneumoniae infection led to an enhanced MyD88-IRAK
immunocomplex formation, which was further augmented by S. pneumoniae in combination
with B7-H3 (p<0.05 versus mice challenged with S. pneumoniae alone) (Fig 3B and 3D). B7-H3
alone had no effect on IRAK1 expression and its complex formation with MyD88 (Fig 3). These
results indicate that B7-H3 amplifies S. pneumoniae-activated TLR2 upstream signaling path-
ways, in particular the formation of MyD88-IRAK immunocomplex.
B7-H3 augments the activation of TLR2 downstream signaling
pathways, NF-κB p65 and MAPK p38, in the brain of S. pneumoniae-
infected mice
We next examined the impact of B7-H3 on activation of NF-κB p65 and MAPK p38, two com-
mon downstream pathways for TLR2 signaling [26,27,31], in S. pneumoniae-infected mice.
Infection with S. pneumoniae induced activation of the NF-κB 65 pathway, as demonstrated by
substantially enhanced phosphorylation of p65 at Ser536 in brain homogenates after mice chal-
lenged with S. pneumoniae (Fig 4A and 4C). Similar activation of the MAPK p38 pathway was
also observed in S. pneumoniae-challenged mice, with markedly enhanced phosphorylation of
Fig 2. Neither S. pneumoniae nor B7-H3 enhances mRNA expression of MyD88, IRAK-1, TIRAP, and TRAF6 in brain tissues of
S. pneumoniae-infected mice. Mice were challenged with PBS as the control, recombinant mouse B7-H3, live S. pneumoniae (SP), or
live S. pneumoniae plus B7-H3 (SP+B7-H3) via intracerebral ventricular injection as described in the Methods. Brain samples were
collected at the indicated time points after challenges and MyD88 (A), IRAK-1 (B), TIRAP (C), and TRAF6 (D) mRNA expression was
assessed by quantitative real-time PCR. Data are expressed as mean ± SD of five to six mice per time point and represent two separate
experiments.
doi:10.1371/journal.pone.0171146.g002
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p38 at Thr180/Tyr182 in brain tissues upon S. pneumoniae infection (Fig 4B and 4D). Notably,
B7-H3 itself did not affect phosphorylation of NF-κB p65 and MAPK p38 (Fig 4). However, fur-
ther substantially increased levels of phosphorylated p65 (Fig 4A and 4C) and p38 (Fig 4B and
4D) were evident in mice challenged with a combination of S. pneumoniae and B7-H3 (p<0.05
versus mice challenged with S. pneumoniae alone), indicating that administration of B7-H3
results in augmented activation of both NF-κB p65 and MAPK p38 pathways in the brain of S.
pneumoniae-infected mice.
Blockage of NF-κB p65 and MAPK p38 attenuates B7-H3-amplified
inflammatory response and ameliorates B7-H3-exacerbated BBB
disruption in S. pneumoniae-infected mice
Having demonstrated that B7-H3 administration strongly augments the activation of TLR2
downstream signaling pathways, NF-κB p65 and MAPK p38, in the brain of S. pneumoniae-
Fig 3. Administration of B7-H3 causes increased MyD88-IRAK immunocomplex formation in brain
tissues of S. pneumoniae-infected mice. Mice were challenged with PBS as the control, recombinant
mouse B7-H3, live S. pneumoniae (SP), or live S. pneumoniae plus B7-H3 (SP+B7-H3) via intracerebral
ventricular injection as described in the Methods. Brain samples were collected at the indicated time points after
challenges. IRAK-1 protein expression was detected by Western blot analysis (A) and MyD88-IRAK immuno-
complex formation was detected by immunoprecipitation (B). Data shown represent one experiment from a total
of three or four separate experiments. Density ratios of IRAK1/GAPDH (n = 4) (C) and MyD88-IRAK/GAPDH
(n = 3) (D) were quantified by densitometry analysis. *p<0.05, **p<0.01 compared with mice treated with PBS,
6¼p<0.05 compared with mice treated with SP alone.
doi:10.1371/journal.pone.0171146.g003
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infected mice, we first attempted to determine whether the augmented activation of NF-κB
p65 and/or MAPK p38 is responsible for B7-H3-amplified inflammatory response. Signifi-
cantly increased proinflammatory cytokine and chemokine TNF-α, IL-1β, IL-6, and MCP-1
mRNA expression (Fig 5) and protein levels (Fig 6) in brain homogenates were observed in
mice infected with S. pneumoniae (p<0.01 versus mice treated with PBS), which was further
augmented in mice challenged with S. pneumoniae and B7-H3 in combination (p<0.05 versus
mice challenged with S. pneumoniae alone) (Fig 5 and Fig 6). Blockage of MAPK p38 in vivo
with its specific inhibitor SB203580 substantially attenuated B7-H3-augmented TNF-α, IL-1β,
Fig 4. Administration of B7-H3 up-regulates phosphorylation of NF-κB p65 and MAPK p38 in brain
tissues of S. pneumoniae-infected mice. Mice were challenged with PBS as the control, recombinant
mouse B7-H3, live S. pneumoniae (SP), or live S. pneumoniae plus B7-H3 (SP+B7-H3) via intracerebral
ventricular injection as described in the Methods. Brain samples were collected at the indicated time points
after challenges. Phosphorylated p65 at Ser536 (A), total p65 (A), phosphorylated p38 at Thr180/Tyr182 (B),
and total p38 (B) was detected by Western blot analysis. Data shown represent one experiment from a total of
four separate experiments. Density ratios of p-p65/p65 (n = 4) (C) and p-p38/p38 (n = 4) (D) were quantified
by densitometry analysis. **p<0.01 compared with mice treated with PBS, 6¼p<0.05 compared with mice
treated with SP alone.
doi:10.1371/journal.pone.0171146.g004
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IL-6, and MCP-1 expression at both the mRNA level (Fig 5) and the protein level (Fig 6) in the
brain of S. pneumoniae-infected mice (p<0.05 versus mice challenged with S. pneumoniae and
B7-H3 in combination). Blockage of NF-κB p65 with its specific inhibitor PDTC caused simi-
lar attenuation in B7-H3-augmented TNF-α, IL-1β, IL-6, and MCP-1 production in S. pneu-
moniae-infected mice (Fig 5 and Fig 6). Of note, blocking both MAPK p38 and NF-κB p65
with SB203580 and PDTC led to further attenuation at the protein level of B7-H3-augmented
proinflammatory cytokines and chemokine in S. pneumoniae-infected mice (p<0.01 versus
mice challenged with S. pneumoniae and B7-H3 in combination) (Fig 6).
We next attempted to determine whether the augmented activation of NF-κB p65 and/or
MAPK p38 is involved in B7-H3-exacerbated BBB disruption and clinical disease status. Mice
challenged with S. pneumoniae displayed disruption of BBB integrity with significantly increased
albumin (Fig 7A) and IgG (Fig 7B) in brain homogenates and showed moderate severity of dis-
ease with substantially decreased spontaneous motor activity (Fig 7C) and increased body weight
loss (Fig 7D) at 30 hrs after infection (p<0.01 versus mice treated with PBS), whereas adminis-
tration of B7-H3 further aggravated BBB disruption (Fig 7A and 7B) and disease severity (Fig 7C
and 7D) in S. pneumoniae-infected mice (p<0.05 versus mice challenged with S. pneumoniae
alone). However, blockage of NF-κB p65 and/or MAPK 38 with their specific inhibitors signifi-
cantly attenuated B7-H3-exaggerated extravasation of serum albumin and IgG into the brain
Fig 5. Blockage of NF-κB p65 and/or MAPK p38 attenuates B7-H3-amplified proinflammatory cytokine and
chemokine mRNA expression in brain tissues of S. pneumoniae-infected mice. Mice were challenged with
PBS as the control, live S. pneumoniae (SP), or live S. pneumoniae plus B7-H3 (SP+B7-H3) 1 hr after mice
pretreated with the MAPK p38 inhibitor SB203580, the NF-κB p65 inhibitor PDTC, or their combination (SB203580
+PDTC) as described in the Methods. Brain samples were collected at 12 hrs after challenges for detecting mRNA
expression of TNF-α (A), IL-1β (B), IL-6 (C), and MCP-1 (D) by quantitative real-time PCR. Data are expressed as
mean ± SD of five to six mice per time point and represent two separate experiments. **p<0.01 compared with
mice treated with PBS, 6¼p<0.05 compared with mice treated with SP alone or SP+B7-H3, εp<0.05 compared with
SP alone.
doi:10.1371/journal.pone.0171146.g005
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(Fig 7A and 7B) and substantially ameliorated B7-H3-exacerbated disease severity (Fig 7C and
7D) in S. pneumoniae-infected mice (p<0.05, p<0.01 versus mice challenged with S. pneumoniae
and B7-H3 in combination). Collectively, these results strongly indicate that activation of both
NF-κB p65 and MAPK p38 pathways is predominantly responsible for B7-H3-amplified inflam-
matory response and is involved in B7-H3-exacerbated disruption of BBB integrity and severity
of disease status during pneumococcal meningitis.
Discussion
In addition to a well documented role of B7-H3 in regulating Ag-specific T cell-mediated
adaptive immune responses [16–19], B7-H3 has been shown to be involved in the innate
immune response by acting as a costimulator of innate immunity to amplify inflammatory
responses [13,21]. B7-H3 markedly enhanced both the TLR4 agonist LPS- and the TLR2 ago-
nist BLP-stimulated proinflammatory cytokine production in monocytes/macrophages,
whereas neutralization of B7-H3 with its blocking mAb MIH 35 significantly attenuated proin-
flammatory cytokine release and protected mice against LPS-associated lethality [21]. By using
a murine model of pneumococcal meningitis, we previously demonstrated that B7-H3 strongly
augmented S. pneumoniae-induced inflammatory response with exacerbated BBB disruption
and aggravated brain injury, which occurs in a TLR2-dependent manner as B7-H3 almost
Fig 6. Blockage of NF-κB p65 and/or MAPK p38 attenuates B7-H3-amplified proinflammatory cytokine and
chemokine production in brain tissues of S. pneumoniae-infected mice. Mice were challenged with PBS as
the control, live S. pneumoniae (SP), or live S. pneumoniae plus B7-H3 (SP+B7-H3) 1 hr after mice pretreated with
the MAPK p38 inhibitor SB203580, the NF-κB p65 inhibitor PDTC, or their combination (SB203580+PDTC) as
described in the Methods. Brain samples were collected at 18 hrs after challenges for detecting protein levels (B) of
TNF-α (A), IL-1β (B), IL-6 (C), and MCP-1 (D) by ELISA. Data are expressed as mean ± SD of five to six mice per
time point and represent two separate experiments. **p<0.01 compared with mice treated with PBS, 6¼p<0.05,
6¼6¼p<0.01 compared with mice treated with SP alone or SP+B7-H3, εp<0.05 compared with SP alone.
doi:10.1371/journal.pone.0171146.g006
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completely lost its amplifying action on S. pneumoniae-induced inflammatory response in
TLR2-deficinet mice [13]. In the present study, we further examined the impact of B7-H3 on
activation of TLR2 signaling and aimed to clarify the component(s) of TLR2-mediated signal
transduction pathways responsible for B7-H3-amplified inflammatory response and subse-
quent brain damage during experimental pneumococcal meningitis. Administration of B7-H3
resulted in an enhanced MyD88-IRAK immunocomplex formation in S. pneumoniae-infected
mice, but had no augmenting effects on expression of TLR2 and other upstream components
including MyD88, IRAK1, TIRAP, and TRAF6. Furthermore, B7-H3 substantially augmented
S. pneumoniae-induced activation of the TLR2 downstream NF-κB p65 and MAPK p38 path-
ways in the brain of S. pneumoniae-infected mice. Remarkably, blockage of NF-κB p65 and/or
MAPK p38 attenuated B7-H3-amplified inflammatory response with significantly reduced
proinflammatory cytokine and chemokine production, and ameliorated B7-H3-exacerbated
disruption of BBB integrity and severity of disease status in S. pneumoniae-infected mice.
TLR2 acts primarily as an innate sensor of gram-positive bacteria such as S. pneumoniae by
detecting their cell wall products including bacterial lipoprotein, peptidoglycan, and lipoteichoic
Fig 7. Blockage of NF-κB p65 and/or MAPK p38 ameliorates B7-H3-exacerbated disruption of BBB integrity and severity of
disease status in S. pneumoniae-infected mice. Mice were challenged with PBS as the control, live S. pneumoniae (SP), or live
S. pneumoniae plus B7-H3 (SP+B7-H3) 1 hr after mice pretreated with the MAPK p38 inhibitor SB203580, the NF-κB p65 inhibitor
PDTC, or their combination (SB203580+PDTC) as described in the Methods. Brain samples were collected at 30 hrs after challen-
ges for detecting albumin (A) and IgG (B) levels using ELISA. The severity of disease status as represented by spontaneous motor
activity (C) and body weight loss (D) was examined 30 hrs after challenges. Data are expressed as mean ±SD of five to six mice per
time point and represent two separate experiments. **p<0.01 compared with mice treated with PBS, 6¼p<0.05, 6¼6¼p<0.01 compared
with mice treated with SP alone or SP+B7-H3, εp<0.05 compared with SP alone.
doi:10.1371/journal.pone.0171146.g007
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acid [28–32]. Upon engagement with these PAMPs of gram-positive bacteria, TLR2 recruits the
adaptor proteins MyD88, IRAK1, and TRAF6 [26–30]. In turn, these adaptor molecules activate
the TLR2-mediated downstream signal transduction pathways NF-κB and MAPKs including
p38, extracellular signal-regulated kinase 1/2 (ERK1/2), and c-Jun NH2-terminal kinase (c-Jun),
which ultimately leads to transcription of the targeted inflammatory genes and production of
proinflammatory cytokines and chemokines [26,27,30,31]. Activation of TLR2 is the first step to
initiate a cascade of the above mentioned intracellular signal events that eventually trigger the
inflammatory response. Previous work has shown that stimulation with bacterial lipoprotein
substantially enhances TLR2 expression and blockage of TLR2 strongly attenuates bacterial lipo-
protein-stimulated TNF-α and IL-6 production [33,34]. Significantly upregulated TLR2 mRNA
expression was also detected in the brain of S. pneumoniae infection-induced experimental pneu-
mococcal meningitis [11]. In the present study, we observed substantially enhanced TLR2
mRNA expression, but not TLR2 protein expression, in the brain of S. pneumoniae-infected
mice, whereas additional B7-H3 challenge failed to further augment S. pneumoniae-stimulated
TLR2 expression. Surprisingly, neither S. pneumoniae nor S. pneumoniae in combination with
B7-H3 affected MyD88, IRAK1, TIRAP, and TRAF6 mRNA expression. Of note, infection with
S. pneumoniae or S. pneumoniae in combination with B7-H3 led to reduced protein expression
of IRAK1. Crucially, administration of B7-H3 further enhanced MyD88-IRAK immunocomplex
formation in the brain of S. pneumoniae-infected mice, indicating that B7-H3 amplifies S. pneu-
moniae-stimulated activation of TLR2 upstream signaling pathways by augmentation of
MyD88-IRAK immunocomplex formation.
NF-κB p65 and MAPK p38 are two common downstream pathways for TLR2 signaling, and
activation of NF-κB p65 and/or MAPK p38 is a critical event to trigger transcription of the tar-
geted inflammatory genes and production of proinflammatory cytokines and chemokines [26–
31]. In the present study, we tested whether B7-H3 is capable of augmenting S. pneumoniae-
induced activation of NF-κB p65 and MAPK 38, thus amplifying inflammatory responses in S.
pneumoniae-infected mice. We demonstrated that infection of mice with S. pneumoniae resulted
in activation of both NF-κB p65 and MAPK 38 pathways. Of note, the additional challenge with
B7-H3 led to further elevations in phosphorylated NF-κB p65 and MAPK p38 in the brain of S.
pneumoniae-infected mice. Having demonstrated the augmenting effect of B7-H3 on S. pneumo-
niae-induced activation of NF-κB p65 and MAPK p38, we further addressed whether these two
key downstream components of the TLR2-mediated signal transduction pathway is indeed
responsible for B7-H3-amplified inflammatory response S. pneumoniae-infected mice. Remark-
ably, blockage of NF-κB p65 and/or MAPK p38 with their specific inhibitors strongly attenuated
B7-H3-amplified TNF-α, IL-1β, IL-6, and MCP-1 production in the brain of S. pneumoniae-
infected mice, suggesting that B7-H3-induced additional activation of both NF-κB p65 and
MAPK p38 is predominantly responsible for B7-H3-amplified inflammatory response during
experimental pneumococcal meningitis.
It has been well documented that a persistent and/or amplified activation of inflammatory
response with the excessive production of proinflammatory cytokines in the CNS can cause
severe damage to the brain and predominantly contributes to a frequently unfavorable out-
come during the development of pneumococcal meningitis [8,10,14]. We therefore asked
whether B7-H3 augmented NF-κB p65 and/or MAPK p38 activation and subsequently ampli-
fied proinflammatory cytokine and chemokine production are responsible for the observed
exacerbation of BBB disruption and severity of disease status in mice challenged with S. pneu-
moniae in combination with B7-H3. We demonstrated that administration of B7-H3 further
aggravated BBB disruption with significantly increased albumin and IgG in the brain, and
intensified disease severity with substantially decreased spontaneous motor activity and
increased body weight loss in S. pneumoniae-infected mice. Remarkably, blockage of either
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NF-κB p65, MAPK 38 or both with their specific inhibitors significantly attenuated B7-H3-ex-
aggerated extravasation of serum albumin and IgG into the brain and substantially ameliorated
B7-H3-exacerbated disease severity in S. pneumoniae-infected mice, indicating that B7-H3
augmented activation of both NF-κB p65 and MAPK p38 pathways and subsequently ampli-
fied inflammatory response is predominantly responsible for B7-H3 exacerbated disruption of
BBB integrity and severity of disease status during pneumococcal meningitis.
Taken together, in this study we demonstrate that administration of B7-H3 results in enhanced
formation of MyD88-IRAK immunocomplex and augmented activation of TLR2 downstream
NF-κB p65 and MAPK p38 pathways in the brain of S. pneumoniae-infected mice. We have fur-
ther shown that blockage of NF-κB p65 and/or MAPK p38 attenuates B7-H3-amplified inflam-
matory response and ameliorates B7-H3-exacerbated BBB disruption and brain damage in S.
pneumoniae-infected mice, suggesting that targeting NF-κB p65 and/or MAPK p38 may repre-
sent a potential therapeutic option for amelioration of overwhelming inflammatory response-
associated brain injury during pneumococcal meningitis.
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